ESC 365 - Baseline cardiovascular risk assessment before cardiotoxic cancer treatment

ESC Professional Premium Access

Baseline cardiovascular risk assessment before cardiotoxic cancer treatment

Session: Cardiovascular disease management in patients with cancer

Topic: Cardio-Oncology

Speaker: Doctor E. de Azambuja (Brussels, BE)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Evandro de Azambuja

Jules Bordet Institute, Brussels (Belgium)

3 presentations

7 followers

3 more presentations in this session

Novel targeted cancer therapies which can cause cardiovascular complications

Speaker: Professor V. Guarneri (Padova, IT)

Cardiovascular complications and surveillance in cancer survivors: who, when, and how?

Speaker: Professor J. Bergler-Klein (Vienna, AT)

Cardiovascular disease management in patients with cancer - patient perspective

Speaker: Mr R. Stephens (Stevenage, GB)

Access the full session

Cardiovascular disease management in patients with cancer

Speakers: Doctor E. de Azambuja, Professor V. Guarneri, Professor J. Bergler-Klein, Mr R. Stephens

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources